- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), and exploratory efficacy of GZ402671 / SAR402671 in enzyme replacement therapy treatment-naïve adult male patients diagnosed with Fabry disease.
Critère d'inclusion
- Fabry Disease